Novasep industrial solutions can provide you with agile custom manufacturing services whether you are producing for gene therapy, vaccines, and immunotherapy - among others.
Biopharmaceuticals
Contract manufacturing services
Novasep News
2017/12/06
Novasep invests €17 M in “mAbulous”, its dedicated...
The facility will address increasing demand for small-volume mAb CDMO services
Novasep News
2017/02/23
Novasep opens €11M new antibody-drug conjugate (ADC)...
ADCs, used in innovative treatments against cancer, will be produced in Le Mans, France to serve international markets
Novasep News
2017/02/13
Novasep Invests in a €27m Viral Vector Production Facility
The strategic investment supports the growing demand for development and commercial phase production of viral-vector...
Novasep News
2016/11/24
VRI, ANRS and Novasep sign an agreement for the cGMP...
Two candidate vaccines targeting dendritic cells have been developed at the Vaccine Research Institute (VRI), and...
Novasep News
2016/11/17
Novasep and Japanese agent AR Brown extend partnership
Stronger local representation in growing Japanese biopharma market will improve Novasep’s capacity to equip and...
Contact
You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!